Amgen to Invest $600M in New Science & Innovation Center at HQ

Amgen plans to invest over $600 million in a new science and innovation center at its U.S. HQ in Thousand Oaks, California. The center will empower scientists with collaborative tools and environments to drive scientific discovery and advance human health. Construction is set to begin in Q3 2025 and will create hundreds of U.S. jobs. The investment reflects Amgen's commitment to American science and innovation.

Amgen Inc. (NASDAQ: AMGN) has announced a significant investment of more than $600 million in a new state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center, slated to commence construction in the third quarter of 2025, is designed to foster collaboration among researchers, engineers, and scientists across various disciplines, with the goal of accelerating the discovery of next-generation therapeutics for patients with serious diseases.

The new facility will feature advanced automation and digital capabilities, providing scientists with the necessary tools and environment to drive scientific excellence and innovation in biotechnology. This investment is part of Amgen's broader commitment to U.S. innovation and reflects the company's substantial investment in manufacturing and research and development since the passage of the Tax Cuts and Jobs Act (TCJA) of 2017. The company has already committed over $40 billion to these efforts, including over $5 billion in direct capital expenditures in the U.S. [1]

The new center will enhance Amgen's global network of sites, leveraging decades of operational expertise and technological advancements. The construction is expected to create hundreds of U.S. jobs, contributing to the local economy and supporting the company's ongoing efforts to advance human health. This investment builds on recent expansions, including a $900 million manufacturing facility expansion in Central Ohio and a $1 billion investment for a second manufacturing plant in Holly Springs, North Carolina.

Amgen's commitment to innovation and investment in the U.S. is evident in its recent recognition as one of the "World's Most Innovative Companies" by Fast Company and "America's Best Large Employers" by Forbes. The company's forward-looking statements emphasize the potential risks and uncertainties associated with its strategic initiatives, including collaborations, acquisitions, and the impact of regulatory environments and global economic conditions.

References:
[1] https://www.marketscreener.com/news/amgen-investing-more-than-half-a-billion-dollars-in-new-state-of-the-art-center-for-science-and-inn-ce7c50d3de8ff725